Free radicals

Worldwide Chlorine Dioxide Industry to 2027 - Rising Demand for Safe Drinking Water is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 16, 2021

The global chlorine dioxide market is primarily driven by surge in demand from industrial sector for the treatment of waste water.

Key Points: 
  • The global chlorine dioxide market is primarily driven by surge in demand from industrial sector for the treatment of waste water.
  • Furthermore, the demand for chlorine dioxide is anticipated to surge significantly from food & beverage industry due to rise in demand for processed food across the globe.
  • However, stringent government regulations against the use of chlorine limit the growth of the global chlorine dioxide market.
  • The profiles of key players and with their key strategic developments are enlisted in the global chlorine dioxide market report.

Carbyne Hosts Global Innovation Summit To Address New World Public Safety Affairs And Emerging Technologies

Retrieved on: 
Wednesday, June 2, 2021

NEW YORK, June 2, 2021 /PRNewswire/ -- Carbyne , a global innovation leader in emergency collaboration,today announces the details and spokesperson lineup for its annual Global Innovation Summit taking place via Zoom tomorrow, June 3, at 12 p.m.

Key Points: 
  • NEW YORK, June 2, 2021 /PRNewswire/ -- Carbyne , a global innovation leader in emergency collaboration,today announces the details and spokesperson lineup for its annual Global Innovation Summit taking place via Zoom tomorrow, June 3, at 12 p.m.
  • The webinar will address yet another challenging year for public safety and law enforcement, and the emerging technologies that have materialized as a result to improve public safety.
  • ABOUT CARBYNE:Founded by Amir Elichai (Chairman & CEO), Alex Dizengoff (CTO), Yony Yatsun (R&D Manager) and Lital Leshem (Shareholder), Carbyne is a global leader in public safety technology.
  • Headquartered in NYC, Carbyne quickly grew to be one of dominant global players in the public safety global industry.

EQS-News: MetrioPharm AG: MetrioPharm Announces Publication of Successful MP1032 Preclinical Data in COVID-19

Retrieved on: 
Thursday, November 5, 2020

MetrioPharm AG, a pharmaceutical company developing drugs for chronic inflammatory diseases, announces the publication of preclinical data showing its lead compound MP1032 could be a promising option for prevention and treatment of the SARS-CoV-2-induced cytokine storm.

Key Points: 
  • MetrioPharm AG, a pharmaceutical company developing drugs for chronic inflammatory diseases, announces the publication of preclinical data showing its lead compound MP1032 could be a promising option for prevention and treatment of the SARS-CoV-2-induced cytokine storm.
  • The article outlines how MP1032 exerts potent immune-modulatory, self-regulated reactive oxygen species (ROS) scavenging, and SARS-CoV-2 specific antiviral properties in in-vitro and in preclinical models of inflammation.
  • Based on these data, MetrioPharm is currently assessing clinical development of MP1032 in COVID-19 patients.
  • These data show that MP1032 simultaneously addresses several crucial pathophysiological processes of a SARS-CoV-2 infection.

Phosplatin Therapeutics Announces Data Revealing Novel Mechanistic Attributes for PT-112 at the 32nd EORTC-NCI-AACR Virtual Symposium

Retrieved on: 
Tuesday, October 27, 2020

The type of cell death induced by PT-112 was also shown to involve autophagy, which is a known pre-cursor of immunogenic cell death (ICD).

Key Points: 
  • The type of cell death induced by PT-112 was also shown to involve autophagy, which is a known pre-cursor of immunogenic cell death (ICD).
  • Data were presented at the 32nd Symposium of the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), which took place virtually October 24-25.
  • These findings may offer opportunity for subsequent clinical applications," said Tyler Ames, PhD, SVP of Research and Development, Phosplatin Therapeutics.
  • The study authors attributed the variance in response to differences in cellular targets and/or reactive oxygen species (ROS) generation by PT-112.

Panasonic announces verification of inhibitory effect of hydroxyl radicals contained in water (nano-sized electrostatic atomized water particle) on novel coronavirus (SARS-CoV-2)

Retrieved on: 
Wednesday, August 26, 2020

Hydroxyl radicals contained in water are particulate ions containing hydroxyl radicals that are generated by applying a high voltage to moisture in the air.

Key Points: 
  • Hydroxyl radicals contained in water are particulate ions containing hydroxyl radicals that are generated by applying a high voltage to moisture in the air.
  • Based on this result, Panasonic announced that "hydroxyl radicals contained in water" technology could be expected to have an inhibitory effect on new viruses*2.
  • A comparative verification was conducted in a 45L test space containing the novel coronavirus (SARS-CoV-2) with and without exposure to hydroxyl radicals contained in water.
  • Note: This verification was designed to generate basic research data on the effects of hydroxyl radicals contained in water on the novel coronavirus in laboratory conditions different from those found in living spaces.

Tropospheric Nitrogen Dioxide Abruptly Declines After Outbreak of COVID-19 Over China

Retrieved on: 
Tuesday, June 30, 2020

COLUMBIA, Md., June 30, 2020 /PRNewswire/ --During the COVID-19 crisis, scientists found that nitrogen dioxidepollution over China substantially decreased for a short period between 30 and 50 days.

Key Points: 
  • COLUMBIA, Md., June 30, 2020 /PRNewswire/ --During the COVID-19 crisis, scientists found that nitrogen dioxidepollution over China substantially decreased for a short period between 30 and 50 days.
  • The efforts soon expanded nationwide, and the policy restrictions, applied at an unprecedented rate, impacted the environment and the economy.
  • The research team first evaluated the reduction in nitrogen dioxide (NO2) measured in tropospheric vertical column density (TVCD) before, during, and after the Chinese Lunar New Year (LNY).
  • Based on the modeling data, the team found that both actions were associated with nearly the same magnitude of reductions.

Genetic Edge Compounds Perfect Complement For Americans Working Out

Retrieved on: 
Friday, February 7, 2020

Another 18 percent of Americans work out one to two hours every day.

Key Points: 
  • Another 18 percent of Americans work out one to two hours every day.
  • That is where Genetic Edge Compounds can help.
  • I started working out about two decades ago, just like many of our customers.
  • That was the impetus of Genetic Edge Compounds, which now plans to promote nationwide five of its most popular supplements:
    N.O.-Flo utilizes a synergistic blend of ingredients and patented ingredients as a support system for nitric oxide production.

Global Nitric Oxide 2019: Therapeutics, Companies and Markets - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 9, 2019

The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • Nitric oxide (NO) can generate free radicals as well as scavenge them.

Nitric Oxide Therapeutics, Companies and Markets, 2018-2019 & Projections to 2023 & 2028

Retrieved on: 
Thursday, August 1, 2019

DUBLIN, Aug. 1, 2019 /PRNewswire/ -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 1, 2019 /PRNewswire/ -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • Nitric oxide (NO) can generate free radicals as well as scavenge them.

Global Nitric Oxide Research Report 2019: Therapeutics, Companies, and Markets 2018-2023 & 2028

Retrieved on: 
Wednesday, May 29, 2019

DUBLIN, May 29, 2019 /PRNewswire/ -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 29, 2019 /PRNewswire/ -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • Nitric oxide (NO) can generate free radicals as well as scavenge them.